MetLife Inc. (NYSE:MET) finished Thursday with an addition of $0.17 to close at $62.44, an upside of 0.27 percent. An average of 1,965,671 shares of common stock have been traded in the last five days. There was a fall of -$0.14 in the past week, and it reached a new high 17 times over the past 12 months. The last 20 days have seen an average of 3,357,738 shares traded, while the 50-day average volume stands at 4,057,245.
MET stock has increased by 0.19% in the last month. The company shares reached their 1-month lowest point of $61.05 on 08/23/23. With the stock rallying to its 52-week high on 01/06/23, shares of the company touched a low of $48.95 and a high of $77.36 in 52 weeks. It has reached a new high 3 times so far this year and lost -13.72% or -$10.25 in price. In spite of this, the price is down -19.29% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
MET stock investors should be aware that MetLife Inc. (MET) stock had its last reported insider trading activity 16 days ago on Aug 09. In this transaction, the insider spent $593,323. EVP, Global Tech. & Ops., PAPPAS BILL, disposed of 2,857 shares at a price of $70.96 on Mar 02. The insider now owns more than $202,733 worth of shares. Prior to that, EVP, Global Tech. & Ops. PAPPAS BILL went on to Sale 11,345 shares at $71.96 each on Feb 27. An amount of $816,386 was transacted.
Valuation Metrics
MetLife Inc. (MET) has a trailing price-to-earnings (P/E) ratio of 28.58. The stock’s beta is 1.08. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.66, the price-to-book (PB) ratio at 1.58, and the price-to-cash flow ratio at 3.93.
The company has a payout ratio of 77.90%. The company’s most recent quarterly dividend payment was $0.52 a share, without any change from last year. Its latest increase dividend $0.02 reported on Tuesday April 25 2023.
Financial Health
Further, the company has a long term debt to equity ratio of 0.58 and a total debt to equity ratio of 0.59 for the quarter ending June 29. Its gross profit as reported stood at $2.86 billion compared to revenue of $69.9 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, MetLife Inc.’s return on assets was 0.30%.
Earnings Surprise
For the three-month period that ended June 29, MetLife Inc. had $675.0 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $370.0 million in the quarter, while revenues were grew 72.16%. The analyst consensus anticipated MetLife Inc.’s latest quarter earnings to come in at $1.87 per share, but it turned out to be $1.94, a 3.70% surprise. For the quarter, EBITDA amounted to $430.0 million. At the end of the quarter ending June 29, MetLife Inc.’s stock balance sheet showed total debt was $106.98 billion. Shareholders own equity worth $752.02 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at MetLife Inc. (MET) price momentum. RSI 9-day as of the close on 24 August was 50.14%, suggesting the stock is Neutral, with historical volatility in this time frame at 16.64%.
As of today, MET’s price is $61.88 -0.22% or -$0.14 from its 5-day moving average. MET is currently trading -0.70% lower than its 20-day SMA and +7.16% higher than its 100-day SMA. However, the stock’s current price level is +15.16% above the SMA50 and -15.97% below the SMA200.
The stochastic %K and %D were 29.01% and 20.33%, respectively, and the average true range (ATR) was 1.18. With the 14-day stochastic at 36.64% and the average true range at 1.20, the RSI (14) stands at 53.34%. The stock has reached 0.15 on the 9-day MACD Oscillator while the 14-day reading was at -0.32.
Analyst Ratings
Goldman downgraded MetLife Inc. (NYSE: MET) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy.
